Nexavar (sorafenib)

pCPA File Number: 20812
Negotiation Status:
Negotiations were not pursued
Indication(s):
Metastatic Progressive Differentiated Thyroid Carcinoma
Sponsor/Manufacturer:
Bayer Inc.
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: